Allergy Diagnostics Market: Notable Developments & Geographical Outlook 2022-2031

The global Allergy Diagnostics Market is likely to exhibit a steady growth, which is attributable to the rising prevalence of asthma and various allergies related to food and drugs. As per a study by FMI, the market for allergy diagnostics is set to grow at a CAGR of around 11.6% during the forecast period from 2021 to 2031.

Request a report sample to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4959

The primary factor driving the growth of the market is the rising incidence of allergies and asthma. According to a study by the Asthma and Allergy Foundation of America, allergies are the sixth major cause of chronic illness, affecting more than 50 million people every year in the U.S.

Also, around 6.1 million children and 20.4 million adults are suffering from asthma in the country. With surging incidence of asthma and allergies, the need for effective diagnostics becomes indispensable, creating growth opportunities for the allergy diagnostics market.

North America is dominating the global allergy diagnostics market. Owing to the increase in the number of well-equipped diagnostics centers and high awareness regarding various ailments, the market in the region is bolstering.

“Leading players are emphasizing on developing fully automated immunoassay systems to improve the efficiency and reduce the testing time. Besides this, some of them are introducing self-diagnostics kits, to ease the application for allergy diagnostic among home users,” says the FMI analyst.

Key Takeaways

  • Diagnostic laboratories have emerged as dominant end user due to the rising prevalence of allergies across the globe.
  • The U.S. and Canada are leading the North America market for allergy diagnostics owing to the high prevalence of asthma in the countries.
  • The U.K. is exhibiting a steady growth favored by the presence of developed medical infrastructure and high consumer spending on healthcare.
  • Driven by the increasing incidence of allergies, India is likely to emerge as a lucrative market for allergy diagnostics market.
  • Based on allergen type, food allergy diagnostics account for the largest revenue share, attributed to high prevalence of allergies due to shellfish, peanuts, and dairy products.

Contact our Market Research Specialist@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-4959

Key Drivers

  • Increasing prevalence of allergies and asthma will fuel the demand for the allergy diagnostics market.
  • Growing adoption of automation in diagnostic will drive the growth of the market.
  • With the emergence of self-diagnostics kits, the market for allergy diagnostics is expected to bolster.
  • Rapid diagnosis and allergy molecule detection is spurring the demand for allergy diagnostics devices.

Key Restraints

  • High cost of installation is hampering the demand for the allergy diagnostics market.
  • Lack of expertise in providing proper diagnosis is a factor restraining the market growth.
  • Stringent regulatory guidelines are posing a challenge for the growth of the market.

Competitive Landscape

Market players operating in the allergy diagnostics market are focusing on receiving product approvals and are engaging in merger and acquisition to expand their reach. For instance,

  • Thermo Fisher scientific Inc. acquired Alfa Aesar, a company based in the U.S., in 2017 to expand their reach in chemical industry.
  • In 2019, Hitachi Chemical Diagnostics, announced that the company have received approval from FDA for its new product named OPTIGEN AP 3600.

 Some of the leading players operating in the market are profiled by FMI are:

  • Hitachi Chemical Co.
  • Ltd Thermo Fisher Scientific, Inc.
  • Siemens Healthineers
  • Danaher Corporation
  • HOB Biotech Group Co
  • bioMérieux
  • Hycor Biomedical Inc.
  • Stallergenes Greer
  • R-Biopharm AG
  • Lincoln Diagnostics, Inc.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/4959

More Insights on FMI’s Allergy Diagnostics Market

The latest market study on global allergy diagnostics market by Future Market Insights gives a detailed segmentation for the forecast period of 2021-2031. In order to gain a better perspective of the global market potential, its growth, trends, and opportunities, the market is segmented on the basis of following criteria:

By Product Type

  • Fungal Allergy Diagnostic
  • Neutral Lactase Enzymes

By Allergen Type

  • Inhaled Allergens
  • Food Allergens
  • Drug Allergens
  • Other Allergens

By Test Type

  • In-vivo allergy tests
  • In-vitro allergy tests

By End User

  • Diagnostic Laboratories
  • Hospitals
  • Academic Research Institutes
  • Other End Users

Explore Other Reports Links from Healthcare Market

Regenerative Medicine Market:- The global Regenerative Medicine Market is anticipated to register a phenomenal growth of 23.9% with an evaluation of around US$ 9.9 Bn by the end of the year 2022 and is further expected to enjoy an estimation of US$ 85.3 Bn by the year 2032.

Hospital Capacity Management Solutions Market:- FMI, an ESOMAR-certified market research firm, states that the global Hospital Capacity Management Solutions Market will reach U.S$ 1.08 Bn in 2022, growing at 4.9% y-o-y in 2022.

Pharmacovigilance Market:- Future Market Insights (FMI) delivers key insights on the global Pharmacovigilance Market in its upcoming outlook titled “Pharmacovigilance Market: Global Industry Analysis and Opportunity Assessment, 2021–2031”.

General Anesthesia Drugs Market:- The General Anesthesia Drugs Market is expected to be adversely impacted by the coronavirus outbreak. The pandemic has largely suspended anesthetic medical procedures, of a non-urgent nature, substantially reducing demand for general anesthesia drugs in the short term.

First Aid Market:- Future Market Insights (FMI), in its latest report titled, “China First Aid Market Assessment and Opportunity 2014–2020”, projects the China First Aid Market to exhibit a CAGR of 6.3% between 2015 and 2020. Adoption of aggressive promotional campaigns are key factors driving growth of the market.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Automated Breast Ultrasound Systems Market New Innovations and Future Expansion 2022-2031

The global Automated Breast Ultrasound Systems Market is projected to expand at approximately 10% CAGR during the forecast period of 2021-2031. Increasing necessity of early detection of breast cancer and accurate diagnostic reports is promoting leading players to develop modern automated diagnosis systems.

Request a report sample with 92 pages to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-606

According to the World Health Organization (WHO), 2.3 million women were diagnosed with breast cancer in 2020, and 685,000 succumbed to the disease globally. Breast cancer is the most prevalent type of cancer in the world, occurring in every country, affecting women of any age after puberty, with slowly increasing rates in adulthood.

Initiatives taken by various governmental and non-governmental bodies such as National Breast Cancer Awareness month are anticipated to positively impact the demand for automated breast ultrasound systems for the early screening of tumors in dense breast tissue.

Surging cases of breast cancer are also being attributed to increasingly sedentary lifestyle and obesity. The implementation of high-frequency sound waves to map breast for creating 3D monochromatic images of tissue and the breast structure is propelling the demand in the market, finds ESOMAR-certified consulting firm FMI in this study.

3D automated breast ultrasound systems have witnessed major progress in the market, especially when they are combined with full-field digital screening mammography (FFDSM). These systems deliver higher accuracy in invasive breast cancer diagnosis and have higher recall features and are gaining popularity in the automated breast ultrasound systems market.

Due to the COVID-19 outbreak, a slight drop in demand was observed in 2020. The stringent lockdown restrictions compelled doctors to limit the breast ultrasound procedures for critical patients only.

Skilled professionals were required to prioritize COVID-19 patients to break the transmission chain of the virus, thus restricting the market demand. Nonetheless, FMI anticipates a strong recovery in the automated breast ultrasound market as cases of breast cancer are surging globally.

According to FMI’s analysis, North America is currently leading in the automated breast ultrasound systems market. Growth in this region can be attributed to rising cases of breast cancer, coupled with robust healthcare infrastructure and increasing research and development in terms of advancements in the digital cancer screening systems.

“The implementation of automated breast ultrasound systems with other technologically advanced cancer screening operations will yield highly accurate results, thereby promoting the rapid adoption of ABUS in diagnostic laboratories and augmenting the market growth,” remarks an FMI analyst.

Discover more about the automated breast ultrasound systems market with figures and data tables, along with the table of contents. You will also find detailed market segmentation on https://www.futuremarketinsights.com/ask-question/rep-gb-606

Key Takeaways

  • The U.S. is dominating the North America automated breast ultrasound systems market due to the rising incidence of breast cancer, coupled with increasing government initiatives regarding awareness of the same among women.
  • In terms of end-user, hospitals are leading the automated breast ultrasound systems.
  • India will provide lucrative opportunities for growth due to increasing per capita income and rising cases of breast cancer in the country.
  • Europe is anticipated to show steady growth in the automated breast ultrasound systems market due to the prevalence of obesity and growing alcohol abuse. Increasing breast cancer cases also will emerge as a chief growth driver in the U.K.

Prominent Drivers

  • Advent of technologically advances screening systems such as 3D automated breast ultrasound systems will propel the demand in the market.
  • Implementation of breast cancer awareness campaigns across various countries will generate demand for automated breast ultrasound systems.
  • Increasing demand for highly accurate digital screening systems will drive market growth.

Key Restraints

  • High cost of standardized training and lack of skilled radiologists is hindering the market growth.
  • Underdeveloped healthcare infrastructure and lack of awareness in emerging economies are hampering the growth in the market.
  • Inability to display calcification and producing false positive reports will negatively impact sales in the market.

Prominent players operating in the automated breast ultrasound systems market profiled by FMI include:

  • GE Electric Co.
  • Siemens A.G.
  • Hitachi Ltd.
  • SonoCiné Inc.
  • Koninklijke

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-606

More Insights on FMI’s Automated Breast Ultrasound Systems Market

The latest market study on the automated breast ultrasound systems market by Future Market Insights gives a detailed segmentation for the forecast period of 2021-2031. In order to gain a better perspective of the global market potential, its growth, trends, and opportunities, the market is segmented on the basis of:

End User

  • Hospitals
  • Diagnostic Imaging Laboratories

Explore Other Reports Links from Healthcare Market

Pipette Controller Market:- Pipette Controller demand is anticipated to be valued at US$ 190 Million in 2022, forecast to grow at a CAGR of 4.6% to be valued at US$ 300 Million from 2022 to 2032.

Automated Cannabis Testing Market:- Automated Cannabis Testing is an advanced integrated information system for the management of all the aspects involved in operations such as financial, medical, administrative, legal, and compliance.

Veterinary Glucometers Market:- Veterinary Glucometers are used to determine the glucose level in the companion animals. The veterinary glucometers are specially used for the dogs and cats.

Cholesterol Monitors Market:- In 2022, it is anticipated that the Cholesterol Monitors Market is valued US$ 2,514.6 million. The cholesterol monitors market is expected to expand at a 7.4% CAGR from 2022 to 2032 and is likely generate US$ 4,502.4 million.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Knee Reconstruction Devices Market Projected to Gain Significant Value through 2022-2031

The global Knee Reconstruction Devices Market is forecast to grow at around 6% CAGR throughout the forecast period of 2021 to 2031.

Request a report sample to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4878

Increasing demand for non-invasive surgery has been aiding the development of effective knee reconstruction procedures. Advancement in healthcare technologies in terms of surgical tools and procedures has positively influenced the market growth.

Market leaders are inclined towards developing cost-effective and portable devices. This will further increase the adoption of knee reconstruction devices, finds ESOMAR-certified consulting firm Future Market Insights in this study.

As per the Center of Orthopedic & Neurosurgical Care & Research, around 1 million hip and knee replacement surgeries are performed in the U.S. every year. It is the most common form of orthopedic surgery performed in the country.

Increasing cases of knee pains from chronic ailments especially in geriatric population across the globe will fuel the knee reconstruction devices market growth.

Development of highly precise and accurate surgical robots, capable of performing knee reconstruction surgeries without hampering the patient’s outcome will accelerate the adoption of knee reconstruction devices across the globe.

A slump in market growth was observed during pandemic as focus shifted away from elective medical processes to catering to the immediate medical emergency. Nonetheless, a steady recovery is on the cards as pandemic subsides and elective medical processes are given green light.

 “Recent advancements in the field of surgical robotics along with integration of artificial intelligence in robotics have led to development of highly specialized surgical procedures. Such developments will fuel the knee reconstruction devices market growth,” as per a FMI analyst. 

Key Takeaways

  • Rising cases of joint reconstruction especially knee and hip joint reconstruction surgeries along with presence of solid healthcare system will boost the knee reconstruction devices market sales in the U.S.
  • Growing geriatric population along with surge in sports related injuries in the U.K. will create lucrative market growth opportunities in the country.
  • Rise in consumer spending habits on healthcare and increasing total knee arthroplasty cases in China will elevate the knee reconstruction devices market sales.
  • Germany is anticipated to experience impressive growth in knee reconstruction devices market on the back of increasing demand for ACL reconstruction surgeries and adoption of femoral drilling techniques in knee reconstruction procedure.
  • Cemented implants are easier to control in terms of occlusion. They also provide superior passive fits while eliminating screw access holes. The cemented implants are forecast to surpass the CAGR of 6% throughout the assessment period.

Contact our Market Research Specialist@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-4878

Prominent Drivers

  • Increasing demand for minimal invasive surgical operations is driving the knee reconstruction devices market sales.
  • Rising prevalence of osteoarthritis in geriatric population is further fuelling the market demand.
  • Introduction of robotic surgical procedures equipped with high accuracy operation capabilities will magnify the market growth.

Key Restraints

  • High purchasing cost of knee reconstruction device and need for associated services are restricting the market demand.
  • Stringent regulatory policies by FDA and other similar bodies hinder the market growth.
  • Increasing post surgery issues and problems with respect to bio-compatibility decelerates the market growth.

Leading players profiled by FMI operating in knee reconstruction devices market include:

  • Arthrex Inc.
  • Corin
  • DePuy Synthes
  • DJO Global
  • Exatech Inc.
  • Japan MDM Inc.
  • Smith & Nephew Plc.
  • Stryker
  • Tornier Inc.
  • United Orthopedics Corporation
  • Zimmer Inc.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/4878

More Insights on FMI’s Knee Reconstruction Devices Market

The latest market study on global knee reconstruction devices market by Future Market Insights gives a detailed segmentation for the forecast period of 2021-2031. In order to gain a better perspective of the global market potential, its growth, trends, and opportunities, the market is segmented on the basis of

Product

  • Cemented Implants
  • Cementless Implants
  • Partial Implants
  • Revision Implants

End User

  • Hospitals
  • Orthopedic Clinics
  • ASCs

Indication

  • Osteoarthritis
  • Rheumatoid Arthritis
  • Trauma
  • Others

Explore Other Reports Links from Healthcare Market

Sonohysterography Catheters Market:- Sonohysterography Catheters Market is likely to cross an estimated market value of US$ 22.5 Million by 2032, while it strengthens its hold in the global market at a CAGR of 5.2% (2022-2032).

Artificial Urinary Sphincter Market:- An ongoing study of the research analysts at Future Market Insights (FMI), offers a thorough quantitative and qualitative assessment of the Artificial Urinary Sphincter Market along with easy to grasp tables, graphs, and figures.

Cardiopulmonary Bypass System Market:- Cardiopulmonary Bypass System is medical device that takes over the function of heart and lungs for temporary basis during the cardiac surgery.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Instrument Cleaners and Detergents Market Projected to Gain Significant Value through 2022-2031

The global Instrument Cleaners and Detergents Market is estimated to register growth at a CAGR of 4.1% during the forecast period 2021-2031, which showcases improvement over a CAGR of 3.5% registered between 2016 and 2020. Rising prevalence of hospital-acquired infections (HAI) and other surgical site infections will drive the growth in the market.

Request a report sample to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-10828

According to the National Nosocomial Infections Surveillance system of the Centers for Disease Control and Prevention (CDC), nearly 27 million surgical procedures are executed in the U.S., out of which, around 5% of surgical site infections are recorded every year. Increasing prevalence of surgical site infections is estimated to spur the demand for effective sanitization, in turn, boosting the sales of instrument cleaners and detergents.

Detergents are anticipated to be the top choice for numerous end-users owing to the increasing focus on point-of-care cleaning products. Detergents are dominating the market with the largest market share and is predicted to reach nearly 73% in the year 2021.

North America is expected to dominate the instrument cleaners and detergents market on the back of high medical care awareness due to the increasing prevalence of chronic diseases and hospital-acquired infections (HAI). The region is anticipated to account for approximately 35% of the instrument cleaners and detergents market in the year 2021 making the region a center point for the market growth.

“Leading market players operating in the instrument cleaners and detergents market are focusing on developing new products such as nitroglycerin spray to cater to the growing demand for sanitization amid COVID-19 outbreak,” says the FMI analyst. 

Key Takeaways

  • In North America, the U.S. is leading the instrument cleaners and detergents market with over 75% of the market share within the region.
  • The U.K. is expected to demonstrate a steady growth at a CAGR of nearly 4% owing to the presence of prominent players and increasing drugs pipeline.
  • Germany, home to the world’s top pharmaceutical companies, is anticipated to account for around 22% of market sales in Europe by 2031.
  • In South Asia, India will account for nearly 38% of market sales in 2021, on the back of increasing patient pool due to the emergence of new diseases.
  • Based on end-users, hospitals are projected to dominate the segment with revenue generation of over US$1.1 billion by 2031.

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-10828

Key Drivers

  • Rising prevalence of hospital-acquired infections (HAI) is expected to fuel the demand for instrument cleaners and detergents.
  • Increasing number of medical procedures and repetitive use of medical equipment are the factors boosting the market growth.
  • Emergence of sanitization amid COVID-19 is propelling the sales of instrument cleaners and detergents.
  • Ongoing expansion of the healthcare infrastructure will provide growth opportunities for the instrument cleaners and detergents market.

Key Restraints

  • Lack of awareness regarding hospital-acquired infections (HAI) might hamper the market growth.
  • Poor healthcare infrastructure and low healthcare expenditure in developing and under-developed economies are the factors restraining the growth of the market.

Competitive Landscape

Leading market players operating in instrument cleaners and detergents market are aiming for strategic collaborations with other market players and emphasizing on expanding their manufacturing facilities in other regions to expand their global market share. For instance,

  • Fortive Corporation, the U.S. based company and Pioneer Square Labs announced formation of a joint innovation studio, in 2020, to create new companies in the industrial technology space.
  • In December 2020, Medline Industries, Inc., the U.S. based company, laid foundation stone for the setting up new project in Slovakia to expand their market sales in Eastern Europe.

Leading players profiled by FMI operating in instrument cleaners and detergents market include:

  • Metrex Research, LLC
  • Ruhof Corporation
  • Case Medical, Inc.
  • Certol International LLC
  • Dr. Weigert
  • Biotrol
  • ORO Clean Chemie AG
  • Medalkan
  • STERIS Plc
  • Getinge Group
  • Ecolab Inc.
  • 3M Co.
  • Cantel Medical Corporation
  • EQT (Schülke & Mayr GmbH)
  • Fortive Corporation (Advanced Sterilization Products)
  • Medline Industries, Inc.

Buy Now@ https://www.futuremarketinsights.com/checkout/10828

More Insights on FMI’s Instrument Cleaners and Detergents Market

The latest market study on global instrument cleaners and detergents market by Future Market Insights gives a detailed segmentation for the forecast period of 2021-2031. In order to gain a better perspective of the global market potential, its growth, trends, and opportunities, the market is segmented on the basis of

By Product Type:

  • Cleaners
    • Liquid Solutions
    • Foam-based Cleaners
    • Gel-based Cleaners
  • Detergents
    • Enzymatic Detergents
    • Neutral Detergents
    • Acidic Detergents
    • Alkaline Detergents

By Process Type:

  • Presoak
  • Manual cleaning
  • Automatic Cleaning
  • Disinfection

By Instrument Type:

  • Surgical instruments
  • Endoscopes
  • Ultrasound
  • Dental Instruments
  • Others

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Specialty Clinics
  • Others

Explore Other Reports Links from Healthcare Market

Arthroscopy Devices Market:- Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Arthroscopy Devices Market.

Irradiation Apparatus Market:- According to a recently published study by Future Market Insights, the Global Irradiation Apparatus Market is estimated to garner US$ 8.0 Billion while exhibiting a 3.5% CAGR during the forecast period.

Therapeutic Respiratory Devices Market:- The Therapeutic Respiratory Devices Market was valued at US$ 47 billion in 2021 and is expected to reach US$ 68.62 billion by 2032, growing at a CAGR of 3.5% from 2022 to 2032.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Sleep Apnea Implants Market – Global Industry In-Depth Study and Demand in Future 2022-2031

The global Sleep Apnea Implants Market is anticipated to expand at an impressive 17.3% CAGR through the forecast year 2021-2031, finds Future Market Insights (FMI) in its new study.

Request a report sample to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-8698

Obstructive sleep apnea (OSA) is a severe sleep disorder that increases the risk of fatal accidents. The need for technologically advanced sleep apnea implants and innovations in the same will be prevalent, enabling growth in the market in the coming years.

According to a medical journal published in the US National Library of Medicine – National Institutes of Health, 30% of the population suffers from sleep-related disorders worldwide. Such disorders are more prevalent in working professionals and older adults.

Various sleep-related problems such as insomnia, jet lag narcolepsy and sleep walking remain undiagnosed. Government and non-government institutions across the globe are conducting awareness programs to educate the masses about the importance of sleep and usage of sleep apnea devices.

For instance, the National Sleep Foundation celebrated Sleep Awareness Week in March 2020, with the theme “My Sleep Health”. Such efforts will propel the demand for sleep apnea devices, providing lucrative opportunities for players in the market.

The COVID-19 pandemic has disrupted medical practices globally, resulting in delays in sleep apnea therapy procedures and screening of patients for treatment eligibility. Nonetheless, with increasing number of cases, the market will witness steady growth post-pandemic, finds the ESOMAR-certified firm FMI in this study.

“Increasing focus on spreading awareness on sleep-related disorders, importance of sleep, and rising investments in research & development in the sector will assist the market growth in near future,” remarks the FMI analyst.

Key Takeaways:

  • As per the study by FMI, the OSA segment is expected to dominate the market, accounting for 90% of the market share during the forecast period.
  • Hypoglossal neurostimulation devices will witness a surge in demand in the sleep apnea implants market.
  • The hospital segment will experience a higher footfall of sleep apnea patients, emerging as a dominant end user.
  • Growth prospects seem bright in the U.S. due to the high prevalence of sleep disorders and conscious efforts made by the government to educate people about sleep-related disorders.
  • Private health insurance, favorable regulatory scenarios, and conducive reimbursements are attracting growth opportunities in Germany.
  • Increasing affordability of healthcare services and prevalent cases of sleep-related disorders will make China a lucrative market.

Discover more about the sleep apnea implants market with figures and data tables, along with the table of contents. You will also find detailed market segmentation on https://www.futuremarketinsights.com/ask-question/rep-gb-8698

Prominent Drivers:

  • Government guidelines regarding prescription reformation will potentially attract end-users, boosting the demand for sleep apnea implants.
  • Implementation of programs based on sleep awareness will generate the demand for technologically advanced sleep apnea implants, thereby fueling the growth of the market.
  • Rising popularity of sleep apnea devices such as wearables will provide growth opportunities to players operating in the sector.

Key restraints

  • High product costs can negatively impact the sales in the market.
  • Expenditure involved in technological advancement of the products will hamper the market growth.

Competitive Landscape

Prominent players operating in the sleep apnea implants market are aiming for higher investments to expand their offerings across the globe. Additionally, players are also focusing on acquisitions and collaborations to expand their product portfolio. For instance:

  • In April 2021, Zoll Medical Corporation, a subsidiary of Asahi Kasei Company, acquired Resipicardia, Inc., to combine its cardiac and respiratory care expertise.
  • In March 2021, Inspire Medical Systems, Inc. received FDA approval for their improved surgical implant procedure for Inspire Airway Therapy for OSA. The new procedure reduced average procedure time for Inspire therapy by approximately 20%.

Leading Players Profiled by FMI in the Sleep Apnea Implants Market include:

  • Inspire Medical Systems
  • Respicardia, Inc.
  • Medtronic Plc
  • LinguaFlex LLC
  • Siesta Medical, Inc.
  • Pillar Palatal LLC/ The Snoring Center
  • Nyxoah SA
  • LivaNova/ImThera

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/8698

More Insights on FMI’s Sleep Apnea Implants Market

The latest market study on global sleep apnea implants market by Future Market Insights gives a detailed segmentation for the forecast period of 2021-2031. In order to gain a better perspective of the global market potential, its growth, trends, and opportunities, the market is segmented on the basis of:

Product

  • Phrenic Nerve Stimulator
  • Hypoglossal Neurostimulation Devices
  • Bone Screw Implant System
  • Flexible Tongue Retractor System
  • Palatal Implants/Pillar Procedure

Indication

  • Central Sleep Apnea
  • Obstructive Sleep Apnea (OSA)

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Office Based Clinics

Explore Other Reports Links from Healthcare Market

Medical Face Shields Market:- Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights, Medical Face Shields Market will grow at over 11% CAGR through 2030.

Medical Ventilators Market:- The Medical Ventilators Market is expanding quickly as more emphasis is being placed on increasing production to meet an unexpected rise in demand during the COVID-19 epidemic.

Insulin Delivery Pens Market:- The global Insulin Delivery Pens Market is expected to enjoy a valuation of US$ 22.4 Bn by the end of the year 2022, and further expand at a CAGR rate of 8.0% to reach a valuation of ~US$ 48.6 Bn by the year 2032.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Advanced Empty Capsule Market to Etch New Growth Ratio with Adoption in Developing Economy

The Global Advanced Empty Capsule Market sales are set to grow at over 8% CAGR during the forecast period of 2021 and 2031, estimates ESOMAR-certified consulting firm Future Market Insights.

To remain ‘ahead’ of your competitors, request for a sample>>> https://www.futuremarketinsights.com/reports/sample/rep-gb-13243

Rising demand for halal-certified products from countries with Muslim population is fueling the demand of advanced empty capsules. Increasing demand for customized capsules within pharmaceutical and nutraceutical industry is bolstering the market growth.

Also, demand for vegetarian-based capsules is increasing in pharmaceutical companies to curb the manufacturing of gelatin-based capsules. As a result, manufacturing companies are amplifying the production of vegetarian-based capsules.

Increasing consumption of vitamin supplements across countries such as Russia, the U.S., Germany and the U.K. is improving the production of empty-capsule. Research and development for drug delivery systems and increasing initiatives undertaken by government is improving the growth.

Technological advancements, favorable government policies and high adoption of oral capsules in pharmaceutical companies are widening the growth opportunities for empty capsule manufacturers over the forecast period.

As per FMI’s analysis, the global advanced empty capsule market is anticipated to surpass a valuation of US$ 1.5 Bn by 2021.

“Increasing demand of vegetarian-based capsule within pharmaceutical companies is accelerating the production, providing lucrative growth opportunities for the manufacturers,” says the FMI analyst.

Key Takeaways from FMI’s Advanced Empty Capsule Market Study

  • In terms of product, oral capsules holds the largest market share, accounting for nearly 90% of advanced empty capsule market
  • Vegetarian-based capsule are exhibiting fast growth at a CAGR of over 10.7% attributing to the high demand from pharmaceutical as well as nutraceutical industry
  • Oral capsules of size ‘0’ is the most preferred advanced empty capsule as compared to the others, registering the highest revenue share of 19.3% in 2021
  • Pharmaceutical industry is expected to be the leading end user segment, accounting for over 62% of market share in 2021
  • India will account for over 60% of advanced empty capsule sales in South Asia on the back of increasing expenditure in the healthcare industry
  • Russia is anticipated to lead the Europe’s advanced empty capsule market, exhibiting the growth of 7.3% CAGR during 2021-2031
  • Advanced empty capsule sales across U.K. are set to grow at nearly 5.2% CAGR backed by expansion of healthcare industry
  • By 2031, Germany is expected to hold nearly 26% of advanced empty capsule market share
  • Due to increased research & development for drug delivery system across Australia, the advanced empty capsule market sales are set to grow at 12.1% CAGR through 2021

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-13243

Competitive Landscape

Product innovation and new launches remain the key strategy for the market players. Key players are investing in the research and development for the innovation of products and for revenue generation.

In March 2021, a leading player CapsCanada, a Lyfe Group, announced the launch of a new manufacturing service for its new liquid-filled hard capsule.

In November 2019, Suheung Co. Ltd., announced the opening of their new EMBO CAPS VG-Alpha capsule facility located in the Long Thanh Industrial Zone. Embocaps® by Suheung’s vegetarian capsule product line includes the EMBO CAPS® VG, EMBO CAPS® VG-ALPHA; both non-animal alternatives to gelatin capsules; and the EMBO CAPS®AP, a non-animal delayed release capsule and the EMBO CAPS® VP, a pullulan based capsule.

In July 2018, another key player, Lonza’s Capsule Delivery Solutions announced the launch of Capsugel Vcaps Gen C capsules based on the carrageenan gelling-agent formulation. With this launch the company is expanding its Lonza’s capsugel hydroxypropyl methyl cellulose (HPMC) product portfolio.

Some of the prominent market players profiled by Future Market Insights operating in advanced empty capsule market include:

  • Capsugel (Lonza)
  • ACG Worldwide
  • Medi-Caps Limited
  • Sunil Healthcare Limited
  • Roxlor LLC
  • CapsCanada Corporation
  • Suheung Co., Ltd.
  • Bright Pharma Caps
  • STERIS Plc
  • Fuji Capsule Co. Ltd.
  • QUALICAPS
  • Others

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-13243

More Insights on the Global Advanced Empty Capsule Market

Future Market Insights, in its latest offering offers an unbiased analysis on the global advanced empty capsule market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of:

Product Type

  • Oral Capsules
    • Dry Formulation
      • Immediate-release capsules
        • Gelatin
        • HPMC
        • Starch
        • Pullulan
      • Delayed-release Capsules
        • Time delayed release capsules
        • Gelatin
        • HPMC
      • Acid-Resistant Capsules
        • Gelatin
        • HPMC
        • HPMCP
      • Enteric Capsules
        • Gelatin
        • HPMC
        • HPMC-AS
    • Liquid Formulation
      • Gelatin
      • HPMC
      • Starch
      • Pullulan

Raw Material

  • Animal Source
    • Contract Type-A (Pork Skin)
    • Type-B Gelatin (Animal Bones & Calf Skin)
    • Fish Bone Gelatin
  • Vegetarian-based
    • Hydroxy Propyl Methyl Cellulose (HPMC)
    • Starch
    • Pullulan

Capsule Sizes

    • Size “000” Capsules
    • Size “00” Capsules
    • Size “0” Capsules
    • Size “1” Capsules
    • Size “2” Capsules
    • Size “3” Capsules
    • Size “4” Capsules
    • Size “5” Capsules

End Use

    • Pharmaceutical
    • Nutraceutical & Cosmetic
    • CROs
    • CMOs

Explore Other Reports Links from Healthcare Market

Arthroscopy Devices Market:- Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Arthroscopy Devices Market.

Irradiation Apparatus Market:- According to a recently published study by Future Market Insights, the Global Irradiation Apparatus Market is estimated to garner US$ 8.0 Billion while exhibiting a 3.5% CAGR during the forecast period.

Therapeutic Respiratory Devices Market:- The Therapeutic Respiratory Devices Market was valued at US$ 47 billion in 2021 and is expected to reach US$ 68.62 billion by 2032, growing at a CAGR of 3.5% from 2022 to 2032.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Stereotactic Planning Software Spending Analysis Positioning and Growing Market Share Worldwide

The global Stereotactic Planning Software Spending Analysis Market is forecast to expand at 4.6% CAGR between 2021 and 2031, as per ESOMAR-certified consulting firm Future Market Insights (FMI).

For more Insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6452

According to the World Health Organization (WHO), in India around 1.9% of people over the age of 60 years are suffering from dementia. Considering the large size of population and rapid demographic changes, the total numbers are expected to reach 6 million by the end of 2040.

Increasing demand for minimally-invasive treatment options has fueled the adoption of stereotactic planning software.  With the help of stereotactic planning software, surgeons will be able to perform surgery with reduced trajectory planning time.

COVID-19 pandemic hindered the stereotactic planning software spending market amid implementation of lockdown, limited production, and travel restrictions. Constant mutation in coronavirus is further straining the healthcare facilities severely delaying the treatment procedures for other ailments.

As social distancing was made mandatory, patient footfall in hospitals reduced unless they were availing emergency services in hospitals. These factors led to decline in stereotactic planning software market.

Recovery is on the horizon as pandemic is subsiding and restoration of supply and distribution networks is taking place. This recovery will assist in boosting stereotactic planning software market sales.

“Surge in neurological diseases like Alzheimer and migraine especially in geriatric population creates financial burdened the healthcare system as well as the patients. To prevent the rising prevalence of neurological disorder, the demand for stereotactic planning software analysis will reducet,” says the FMI analyst

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-6452

Key Takeaways

  • The U.S. is expected to account for about 82% of North America market by the end of 2031. The rapid growth can be attributed to elevated healthcare spending and rising incidences of neurological disorders in the country.
  • Establishment of modern healthcare infrastructure and increasing government investment in medical sector will accelerate the market growth in the U.K. The demand in the country is anticipated to increase at 4% CAGR throughout the assessment period.
  • China is expected to dominate the East Asia region and is expected to cover around 65% overall stereotactic planning software in the region. Increase in stroke related deaths in China will drive the market growth.
  • Rising cases of dementia and epilepsy in India along with increasing government initiatives to develop healthcare infrastructure will drive the market growth during the forecast period.
  • Integrated stereotactic planning solution localization tools are attached with the patient’s medical record for smoother and efficient workflows. Integrated stereotactic planning solutions are forecast to remain highly sought after for end-users since they efficiently reduce accommodation space and are easy to use.

Some of the leading companies operating in the planning software spending analysis market are:

  • Brainlab, Inc.
  • Renishaw Inc.
  • inomed Inc.
  • RaySearch Americas, Inc.
  • Mevis Informática Médica
  • FHC, Inc.
  • Integra LifeSciences Corporation
  • Elekta Solutions AB
  • SurgiFRONT Ltd.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/6452

More Insights on the Global Stereotactic Planning Software Spending Analysis Market

Future Market Insights, in its new offering, provides an unbiased analysis of the stereotactic planning software spending analysis market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the stereotactic planning software spending analysis market with a detailed segmentation on the basis of

By Solution Type:

  • Stand-alone Stereotactic Planning Solution
  • Integrated Stereotactic Planning Solution
  • Services
    • Consulting & Implementation
    • Training Services
    • On-demand Support Services

By Imaging Modality:

  • CT Images
  • MR Images
  • Angiographic Images

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

Explore FMI’s Extensive Coverage on the healthcare domain

Medical Face Shields Market:- According to a latest study by Future Market Insights, Medical Face Shields Market will grow at over 11% CAGR through 2030.

Medical Ventilators Market:- The Medical Ventilators Market is expanding quickly as more emphasis is being placed on increasing production to meet an unexpected rise in demand during the COVID-19 epidemic.

Insulin Delivery Pens Market:- The global Insulin Delivery Pens Market is expected to enjoy a valuation of US$ 22.4 Bn by the end of the year 2022, and further expand at a CAGR rate of 8.0% to reach a valuation of ~US$ 48.6 Bn by the year 2032.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

U.S. Digital Ovulation Test Kit Market Detail Analysis of Current and Future Projection 2022-2031

The U.S. Digital Ovulation Test Kit Market grew at about 4% CAGR until 2020, according to a study by Future Market Insights (FMI). The U.S. digital ovulation test kit market is expected to reach US$ 95.1 Mn by 2031, expanding at a CAGR of 9.6% for 2021 – 2031.

For more Insights into the Market, Request a Sample of this Report https://www.futuremarketinsights.com/reports/sample/rep-gb-13241

The demand for digital ovulation test kits will accelerate in response to the increase in working women population and rising need of self-sustained digital ovulation test kits.

As per data from Centers for Disease Control and Prevention (CDC), around 6% of married women in the U.S. aged 15-44 years were unable to conceive in 2019.

The report also states that approximately 12% of 15-44 years aged women face difficulty in conceiving or carrying a pregnancy even after trying for one year.

Rising necessity for cost-efficient and accurate digital ovulation test kits in the market for fertility monitoring will increase the demand for digital ovulation kits in the U.S.

Key manufacturers are focusing on initiating various awareness campaigns and online education programs to spread awareness regarding PCOS and PCOD in women. The collaboration between government and healthcare organization to improve fertility rates across the nation will elevate the market demand.

Digital ovulation test kits assist users to keep an eye on fertility disorders. The rapid adoption of digital strip readers for ovulation tests creates an ideal environment for market growth.

Line indicator ovulation test kits have become outdated as women find it difficult to interpret test results. Digital ovulation test kits provide direct results in the form of digital display. The new models can connect to your smartphone and deliver the results.

As per a study conducted by Clearblue regarding feasibility, it became evident that the use of digital devices has reduced the chances of errors and misinterpretation by around 70%. High accuracy and ease of use will fuel the market demand in upcoming years.

 “Extensive research and development in the field of ovulation test kits led to invention of digital ovulation testing kits with smartphone connectivity to track the fertility hormones. Focus on innovation will drive the U.S. digital ovulation test kits market during the forecast period,” says a FMI analyst

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-13241

Key Takeaways

  • Branded digital ovulation test kits are dominating the U.S. market, accounting for about 85% of total market share in 2021. Extensive marketing using online portals like Amazon and EBay will fuel the market demand.
  • Private label test kits are gaining significant grounds and are expected to experience significant growth during forecast period. The private label kits are promoted in high profile meetings and medical conferences leading to increased market sales.
  • High availability of digital ovulation test kits in pharmacies and hospitals assisted the institutional sales segment to generate significant market revenue. Institutional sales generate more than 54% of total maximum revenue generation in U.S.
  • Digital ovulation test kits market has observed a slight dip in demand owing to its high prices. With regional market players developing cheaper kits, a healthy demand is expected throughout the assessment period.
  • Invention of new products alternative to digital ovulation test kits and increasing cases of product recalls will hamper the market growth.

 Competitive Landscape

According to the study by Future Market Insights, the main area of focus among all market players is rapid product development and new product launches to strengthen their market position.

The market players are working towards increasing consumer awareness to gain a competitive edge in this consolidated market.

Samplytics Technologies Private Limited developed a smartphone-connected device named “Inito Fertility Monitor” and launched it in November 2020. The device is effective to identify up to 6 fertile days to measure estrogen and luteinizing fertility hormones.

To enhance commercialization, leading market players are employing collaborative promotion and marketing strategies to increase their visibility in this cut throat environment. Such strategies will heighten the popularity of digital ovulation test kits in the market.

Wal-Mart and Amazon have partnered with leading manufacturers such as Church & Dwight Co. Ltd. The aim is to use e-commerce portals to bolster overall brand image and promote digital ovulation test kits.

Some of the leading companies operating in the U.S. digital ovulation test kits market are:

  • Swiss Precision Diagnostics GmbH
  • Church & Dwight Co., Inc.
  • Gregory Pharmaceutical Holdings, Inc.
  • Sugentech, Inc.
  • iXensor Co. Ltd
  • Samplytics Technologies Private Limited
  • Bio-AMD

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/13241

More Insights on the Global U.S. digital ovulation test kits Market

Future Market Insights, in its new offering, provides an unbiased analysis of the U.S. digital ovulation test kits market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the U.S. digital ovulation test kits market with a detailed segmentation on the basis of:

By Product:

  • Branded Test Kits
  • Private Label Test Kits

By Distribution Channel:

  • Institutional Sales
  • Hospital Pharmacies
  • Gynaecology Clinics
  • IVF Clinics
  • Maternity Care Centers

Retail Sales

  • Retail Pharmacies
  • Drug Stores
  • Hypermarkets & Supermarkets
  • Online Sales

Explore FMI’s Extensive Coverage on Healthcare Domain

Arthroscopy Devices Market:- Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Arthroscopy Devices Market.

Irradiation Apparatus Market:- According to a recently published study by Future Market Insights, the Global Irradiation Apparatus Market is estimated to garner US$ 8.0 Billion while exhibiting a 3.5% CAGR during the forecast period.

Therapeutic Respiratory Devices Market:- The Therapeutic Respiratory Devices Market was valued at US$ 47 billion in 2021 and is expected to reach US$ 68.62 billion by 2032, growing at a CAGR of 3.5% from 2022 to 2032.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Pharmaceutical Caps and Closure Market Report Covers Trends, Demand, Growth, and Forecast 2031

According to ESOMAR-certified consulting firm Future Market Insights, the global Pharmaceutical Caps and Closure Market is slated to increase, expanding at a CAGR of 5% in 2021.

To remain ‘ahead’ of your competitors, request for a sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13237

The market is anticipated to surpass a valuation of US$ 2.27 billion by 2021-end on the back of growing demand of safe and easy packaging solutions of pharmaceuticals. Growing demand of child-proof packaging due to the rising concern of accidental consumption will spur the growth.

Expansion of pharmaceutical sector across developed regions such as the U.S., U.K., and Germany is enabling the growth of market. Also, focus on effective packaging to lessen the spoilage of pharmaceutical drugs will improve the adoption of pharmaceutical caps and closures.

Sustainability concerns and easy availability have increased the demand of lightweight packaging, especially plastic pharmaceutical caps and closures. However, stringent regulations associated with use of plastics within pharmaceutical and food & beverage industries might impede the market growth.

Furthermore, rising prevalence of chronic diseases such as cardiovascular disease and other diseases have increased the demand for various medications. This in turn, is enabling the demand for effective packaging solutions in the pharmaceutical sector, widening the growth opportunities for the market players.

Advancement in technology and need for smart yet cost-effective packaging is anticipated to fuel the demand of pharmaceutical caps & closures during the forecast period. Smart packaging is needed for the safety and to maintain the quality of product without any accidental consumption of drugs by children.

Considering this, demand for tamper-resistant and child-resistant pharmaceutical caps and closures will bolster the market growth throughout the forecast period. As per the FMI’s analysis, child resistance functionality segment is expected to register maximum growth in the pharmaceutical caps and closure market.

“Rising demand for smart and safe packaging solutions within the pharmaceutical sector is creating growth opportunities for market players throughout the forecast period,” says the FMI analyst.

Get Access to Research Methodology Prepared by Experts@ https://www.futuremarketinsights.com/ask-question/rep-gb-13237

Key Takeaways from FMI’s Pharmaceutical Caps and Closures Market Study

  • In terms of functionality, child resistance closures is anticipated to be one of the most lucrative segment, accounting for over 61% market sales
  • Screw cap and closures are leading the product type segment and will account for more than 46% of market share through 2031
  • By material, plastic caps and closure account for maximum sales of over 64% during the forecast period
  • Anti-cancer drugs segment will exhibit faster growth, registering a CAGR of around 7.5% over the forecast period
  • Small molecule drug modalities segment will witness a steady growth and will account for 60% of global market share
  • The U.S. will emerge as the most lucrative market of pharmaceutical caps and closures, accounting for over 89% of market share
  • Heavy presence of leading players and improvement in production capacities across U.K. will bolster the market growth
  • Germany will emerge as potential market, registering a growth of 6.7% throughout the forecast period
  • Increased healthcare and pharmaceutical expenditure in Japan will stimulate the sales of pharmaceutical caps and closure within the country
  • China will lead the pharmaceutical caps and closure market in East Asia, exhibiting a growth of 8% CAGR through 2021

Some of the prominent market players profiled by Future Market Insights operating in pharmaceutical caps and closure market include:

  • Berry Global Inc.
  • Amcor Plc
  • Aptar, Inc.
  • Closure Systems International, Inc.
  • O.Berk Company, LLC
  • Bericap GmbH and Co KG
  • UNITED CAPS
  • CL Smith Company
  • Georg MENSHEN GmbH & Co. KG
  • WestRock Company
  • West Pharmaceutical Services, Inc
  • Drug Plastics & Glass Co Inc.
  • Gerresheimer AG
  • DWK Life Sciences GmbH
  • Parekhplast India Limited
  • Parshva Exim Limited
  • Others

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/13237

More Insights on the Global Pharmaceutical Caps and Closures Market

In its latest report on global pharmaceutical caps and closure market, FMI provides deeper insights on the key trends of the market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of:

Product type

  • Screw Caps & Closure
  • Snap Caps & Closure
  • Push-Pull Caps & Closure
  • Stopper & Seals
  • Others

Functionality

  • Child Resistant
  • Tamper-evident

Material type

  • Plastic
  • Elastomer
  • Metal

Availability

  • Prescription (Rx) Pharmaceuticals
  • “Over-the-Counter (OTC) Pharmaceuticals”

Drug Modality

  • Small Molecule (Synthetic Drugs)
  • Biopharmaceuticals

Therapeutic Class

  • Anticancer Drugs
  • Anti-Infective Drugs
  • Anti-viral Drugs
  • Anti-bacterial Drugs
  • Anti-fungal Drugs
  • Others
  • Cardiovascular Drugs
  • Anti-inflammatory Drugs
  • Analgesics Drugs
  • Anti-diabetics
  • Ophthalmic Drugs
  • Neurological Drugs
  • Others

End Users

  • Pharmaceutical & Biotechnology Companies
  • Contract Manufacturing Organizations (CMO)
  • Contract Research Organization (CRO)
  • Academic & Research Institutes

Explore Other Reports Links from Healthcare Market

Medical Face Shields Market:- According to a latest study by Future Market Insights, Medical Face Shields Market will grow at over 11% CAGR through 2030.

Medical Ventilators Market:- The market for Medical Ventilators was estimated at US$ 1.2 billion in 2019 and is anticipated to grow at a CAGR of 8.7% over the following five years (2020–2030).

Insulin Delivery Pens Market:- The global Insulin Delivery Pens Market is expected to enjoy a valuation of US$ 22.4 Bn by the end of the year 2022, and further expand at a CAGR rate of 8.0% to reach a valuation of ~US$ 48.6 Bn by the year 2032.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Wearable Medical Devices Market is expected to generate a revenue of USD 73.48 Billion by 2032

ESOMAR-certified consulting firm Future Market Insights’ report has projected the global Wearable Medical Devices Market to grow at a healthy CAGR between 2021 and 2031. Rising prevalence of diabetes and cardiovascular disease have been fuelling the demand of wearable devices across the globe.

For more Insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-826

Innovations in biopharmaceutical industry and rising prevalence of chronic diseases such as diabetes are favoring the market growth. Surging consumer demand for health and fitness solutions and technological developments in the medical field are major factors bolstering the demand for wearable therapeutic medical devices.

Integration of artificial intelligence with the smartphones and wearable medical devices have increased the adoption, furthering the demand. Burgeoning cases of diabetes across the glove have improved the adoption of glucose monitoring devices, especially among the geriatric population.

Also, due to the penetration of online platforms and increasing awareness about health, the demand for home healthcare wearable medical devices have increased exponentially. Furthermore, increasing expenditure in the healthcare industry across countries such as India, US, China, and UK have propelled the market demand.

According to the latest insights of Future Market Insights, the global wearable devices market is poised to expand at over 7% CAGR throughout the forecast period of 2021 and 2031.

“Growing demand for portable and advanced medical devices to monitor the glucose level and heart rate, due to the increasing cardiovascular diseases and diabetes cases, has been encouraging manufacturers to incorporate technologies such as artificial intelligence and Internet of Thinking (IoT). This will pave way for the expansion of the wearable devices market over the forecast period,” says the FMI analyst

Key Takeaways

  • Wearable therapeutic medical devices accounted for more than 50% of global market share in terms of product type
  • Home healthcare wearable devices segment is expected to be the largest contributor in the market revenue, accounting for over 60% of market share
  • Clinics are anticipated to be the primary distribution channel for wearable medical devices market, followed by hospital pharmacies
  • Increased healthcare expenditure across the U.S. are expected to foster the wearable devices sales
  • Germany is expected to lead the Europe’s wearable medical devices market through 2021
  • Favorable policies and high investment in the medical field across China are expected to bolster market growth

Get Customization on this Report for Specific Country https://www.futuremarketinsights.com/customization-available/rep-gb-826

Competitive Landscape

Future Market Insights projects the market is moderately consolidated with the leading players focused on product innovation and new launches to maintain a strong foothold in the industry. Strategic mergers, collaborations and acquisition are some of the other few strategies to solidify their position in the industry.

In May 2021, Nemaura Medical Inc. announced the purchase of 5000 sugarBEAT transmitters and 200,000 sugarBEAT sensors from a leading company in UK, DB Ethitronix Ltd., that launched sugarBEAT non-invasive daily wear glucose monitoring device in UK.

Some of the prominent wearable medical devices manufacturers profiled by FMI are:

  • Siemens AG
  • Medtronic PLC
  • Bayer AG
  • Fitbit Inc.
  • Animas Corporation
  • Panasonic Corporation
  • Smiths Medical
  • Johnson & Johnson
  • Owlet Baby Care
  • Koninklijke Philips NV
  • Hoffmann-La Roche Ltd.
  • OMRON Corporation
  • Rest Devices Inc.

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-826

More Insights on the Global Wearable medical devices Market

Future Market Insights, in its latest study, provides an unbiased analysis of the wearable medical devices market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the wearable medical devices market with a detailed segmentation on the basis of:

Product Type:

  • Wearable Monitoring and Diagnostic Devices
  • Fetal and Obstetric Devices
    • Wearable Fetal Monitors
    • Infant Motion Sensing Monitors
  • Continuous Glucose Monitoring Devices
  • Cardiac Monitoring Devices
    • Wearable Heart Rate Monitors
    • Wearable Pulse Oximeters
    • Wearable Blood Pressure Monitors
  • Wearable Therapeutic Medical Devices
  • Hearing Aid
  • Insulin Pump
  • Respiratory Therapy Devices
    • Sleep Apnea Devices
    • Non-invasive Ventilation
  • Health & Fitness Devices

Application:

  • Patient Monitoring
  • Home Healthcare
  • Health and Fitness

Distribution Channel

  • Hospital Pharmacies
  • Clinics
  • Online Channels
  • Hypermarkets

Explore FMI’s Extensive Coverage on the Healthcare Domain

Portable Anesthesia Systems Market:- The Global Portable Anesthesia Systems Market is expected to accumulate US$ 462.8 Million in value by 2022-2032.

Artificial Urinary Sphincter Market:- The Artificial Urinary Sphincter Market is expected to reach US$ 441.7 million in 2022 and rise at a CAGR of 5.2% to reach US$ 769.2 million by 2032.

Stabilometric Platform Market:- The Stabilometric Platform is a device which measures body movements of subjects by means of a Stabilometer (in standing position), assuming that the stabilometer is a force measuring platform.

Sonohysterography Catheters Market:- Sonohysterography Catheters Market is likely to cross an estimated market value of US$ 22.5 Million by 2032, while it strengthens its hold in the global market at a CAGR of 5.2% (2022-2032).

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs